A model screening pipeline for bile acid converting anti-Clostridioides difficile bacteria reveals unique biotherapeutic potential of Peptacetobacter hiranonis
A. A. Vinithakumari, B. G. Hernandez, S. Ghimire, S. Adams, C. Stokes, I. Jepsen, C. Brezina, O. Sahin, G. Li, C. Tangudu, C. Andreasen, G. J. Phillips, M. Wannemuehler, A. E. Jergens, J. Scaria, , S. Mooyottu
The paper develops a screening pipeline to identify bile acid converting bacteria with anti-C. difficile properties, isolating Peptacetobacter hiranonis with unique biotherapeutic potential.
bioRxiv · Sep 29, 2021 · PreprintMicrobiology